Alibaba Health Information Technology Ltd
00241: XHKG (HKG)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| HKD 3.00 | Fdhgv | Lgkcxychl |
Alibaba Health Gaining Traction in Healthcare E-Commerce and on Track to Profitability
Business Strategy and Outlook
We expect narrow-moat Alibaba Health, or AliHealth, to benefit from low saturation in healthcare e-commerce, leading to 30% year-on-year revenue growth for the next two years. The business is still in the early phase where it is focused on mass user adoption and should see robust growth in the near term.